Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
J Pediatric Infect Dis Soc ; 6(3): 239-244, 2017 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-27012274

RESUMO

BACKGROUND: During January-February 2015, Cook County Department of Public Health led an investigation of a measles outbreak predominantly affecting infants at a child care center who were too young for routine immunization with measles-mumps-rubella (MMR) vaccine. METHODS: Measles cases and contacts were investigated by Illinois public health officials. Cases were isolated for 4 days after rash onset. Exposed healthcare workers and child care center staff were required to provide documentation of receipt of 2 doses of MMR vaccine or laboratory evidence of immunity to return to work. Susceptible contacts were actively monitored for 21 days after exposure and provided postexposure prophylaxis (PEP) if certain criteria were met. RESULTS: Fifteen confirmed measles cases were identified; 12 (80%) occurred in infants who were attendees of a child care center. Clinical misdiagnosis of 1 case allowed for continued transmission within the center. Twelve (86%) of 14 exposed infants at the child care center were diagnosed with measles; no other attendees or staff were infected. Five cases visited outpatient pediatric clinics during their infectious period, exposing 33 infants. Six exposed child care center staff and 3 healthcare workers did not have documentation of immunity available and were excluded from work until this was obtained. No healthcare-associated transmission was identified. Ninety-one contacts were actively monitored and 20 received PEP. CONCLUSIONS: This outbreak underscores the vulnerability of infants to measles, the need for early consideration of measles in susceptible patients presenting with a febrile rash illness, and the importance of immunity among individuals working closely with infants.


Assuntos
Creches , Surtos de Doenças/estatística & dados numéricos , Sarampo/epidemiologia , Adulto , Criança , Pré-Escolar , Feminino , Humanos , Illinois/epidemiologia , Lactente , Masculino , Vacina contra Sarampo-Caxumba-Rubéola/uso terapêutico
2.
MMWR Morb Mortal Wkly Rep ; 65(29): 731-4, 2016 Jul 29.
Artigo em Inglês | MEDLINE | ID: mdl-27467572

RESUMO

Mumps is an acute viral disease characterized by fever and swelling of the parotid or other salivary glands. On May 1, 2015, the Illinois Department of Public Health (IDPH) confirmed a mumps outbreak at the University of Illinois at Urbana-Champaign. IDPH and the Champaign-Urbana Public Health District (C-UPHD) conducted an investigation and identified 317 cases of mumps during April 2015-May 2016. Because of sustained transmission in a population with high 2-dose coverage with measles-mumps-rubella (MMR) vaccine, a third MMR dose was recommended by IDPH, C-UPHD, and the university's McKinley Health Center. No formal recommendation for or against the use of a third MMR dose has been issued by the Advisory Committee on Immunization Practices (ACIP) (1). However, CDC has provided guidelines for use of a third dose as a control measure during mumps outbreaks in settings in which persons are in close contact with one another, where transmission is sustained despite high 2-dose MMR coverage, and when traditional control measures fail to slow transmission (2).


Assuntos
Surtos de Doenças/prevenção & controle , Vacina contra Sarampo-Caxumba-Rubéola/administração & dosagem , Caxumba/epidemiologia , Caxumba/prevenção & controle , Universidades , Adolescente , Adulto , Centers for Disease Control and Prevention, U.S. , Feminino , Humanos , Illinois/epidemiologia , Esquemas de Imunização , Masculino , Pessoa de Meia-Idade , Guias de Prática Clínica como Assunto , Estados Unidos , Adulto Jovem
3.
MMWR Morb Mortal Wkly Rep ; 63(36): 798-9, 2014 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-25211545

RESUMO

On August 19, 2014, CDC was notified by Children's Mercy Hospital in Kansas City, Missouri, of an increase (relative to the same period in previous years) in patients examined and hospitalized with severe respiratory illness, including some admitted to the pediatric intensive care unit. An increase also was noted in detections of rhinovirus/enterovirus by a multiplex polymerase chain reaction assay in nasopharyngeal specimens obtained during August 5-19. On August 23, CDC was notified by the University of Chicago Medicine Comer Children's Hospital in Illinois of an increase in patients similar to those seen in Kansas City. To further characterize these two geographically distinct observations, nasopharyngeal specimens from most of the patients with recent onset of severe symptoms from both facilities were sequenced by the CDC Picornavirus Laboratory. Enterovirus D68 (EV-D68) was identified in 19 of 22 specimens from Kansas City and in 11 of 14 specimens from Chicago. Since these initial reports, admissions for severe respiratory illness have continued at both facilities at rates higher than expected for this time of year. Investigations into suspected clusters in other jurisdictions are ongoing.


Assuntos
Enterovirus Humano D/isolamento & purificação , Infecções por Enterovirus/complicações , Infecções Respiratórias/virologia , Índice de Gravidade de Doença , Adolescente , Criança , Pré-Escolar , Enterovirus Humano D/classificação , Infecções por Enterovirus/diagnóstico , Feminino , Humanos , Illinois , Lactente , Masculino , Missouri
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...